TITLE

How $4 drugs may change health care

AUTHOR(S)
Gresham, Lynn
PUB. DATE
November 2006
SOURCE
Employee Benefit News;Nov2006, Vol. 20 Issue 14, p9
SOURCE TYPE
Periodical
DOC. TYPE
Editorial
ABSTRACT
The author reflects on how the introduction of the $4 drug for a 30-day supply by Wal-Mart can change health care in the U.S. Greater awareness of drug pricing and use of generic drugs over branded drugs will promote health care consumerism, with the consumers looking into the price versus value and obtaining valuable information on what they need and where to get it.
ACCESSION #
22983969

 

Related Articles

  • Wal-Mart envisions larger role in health care. Troy, Mike // Drug Store News;12/8/2008, Vol. 30 Issue 15, p18 

    The article reports on the generic drug-pricing initiatives developed by Wal-Mart Stores Inc. in the U.S. June 2008. It mentions that it is the company's move to help customers save their money on generic drugs by more than $1.1 billion since it went into effect in 2006. The company claims that...

  • Wal-Mart's $4 generic solution 'pretty darn good deal'. Lisanti, Tony // Drug Store News;10/9/2006, Vol. 28 Issue 13, p15 

    The author reflects on the effort of Wal-Mart Stores Inc. for lowering their prices to almost 300 generic drugs in the U.S. He cites that such move of Wal-Mart can have an impact over the next several years. He added that it presents the start of a movement into low drug prices, not only on...

  • Whoever at Wal-Mart thought of $4 prescriptions. Molpus, Jim // HealthLeaders Magazine;Nov2007, Vol. 10 Issue 11, p34 

    The article focuses on the move of Wal-Mart to sell over 300 generic drugs for only $4. The drugs include the diabetes drug metformin, the anticoagulant warfarin and the antibiotic amoxicillin. The author applauds Wal-Mart's initiative but notes that the company has 3,810 pharmacies in the U.S....

  • Wal-Mart's generic drug plan contains obvious benefits.  // Business Insurance;9/25/2006, Vol. 40 Issue 39, p8 

    The article comments on the move of Wal-Mart Stores Inc. to cut the price of a 30-day supply of many generic prescription drugs. Wal-Mart is launching the program in the Tampa Bay, Florida, area and plans to expand it. With the average cost for a month's supply of generic drugs at nearly $30,...

  • Wal-Mart solidifying claim as health leader. TROY, MIKE // Retailing Today;5/26/2008, Vol. 47 Issue 6, p3 

    The article reports on the changes in the drug pricing programs of Wal-Mart Stores Inc. in the U.S. Particular focus is given to the expansion of the generic drug program of the company. According to John Agwunobi, president of the professional services division of Wal-Mart, the expansion of the...

  • Free Drugs! Moynihan, Michael // Reason;Nov2007, Vol. 39 Issue 6, p7 

    The article reports on the competition among several firms to offer cheaper generic medications in the U.S. A $4 prescription drug plan was launched by Wal-Mart in July 2007. Kmart responded to Wal-Mart by pricing a number of generics at $15 for a 90-day supply. A spokesman for the Public...

  • Wal-Mart to Cut Drug Prices. Bowers, Katherine // WWD: Women's Wear Daily;9/22/2006, Vol. 192 Issue 62, p19 

    The article reports on the plan of retailer Wal-Mart to reduce prices on 291 generic drugs in 65 stores in the Tampa, Florida region in September 2006. The drugs, available to Wal-Mart employees as well as customers, will sell for $4 per prescription compared with as much as $30 for a 30-day...

  • Wal-Mart's $4 Rx rattles competition. Troy, Mike // Retailing Today;10/9/2006, Vol. 45 Issue 18, p3 

    The article reports on the impact of Wal-Mart Stores Inc.'s $4 generic pricing program on its competitors in the U.S. The retailer lowered prices on 291 generic prescriptions to $4 and aimed to take it to as many states as possible. In response to the program, Target immediately matched it and...

  • Launch of $4 prescription plan helps discounters stake claim to pharmacy biz. Craig, Tim // Retailing Today;10/9/2006, Vol. 45 Issue 18, p8 

    The article analyzes the rationale behind Wal-Mart Stores Inc.'s $4 generic drug campaign in the U.S. Big-box retailer supporters called it a democratic decision, pointing to the benefits gained when leveraging the weight on the retailer. The neutralists asserted that the move shifts power away...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics